Approval · Notice of Compliance 37075 · 2026
PMS-DEXTROAMPHETAMINE: Notice of Compliance 37075
Issued March 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37075
- Date
- March 10, 2026
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DEXEDRINE (Paladin Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-DEXTROAMPHETAMINE | 02566605 | Marketed |
Medicinal ingredients
- DEXTROAMPHETAMINE SULFATE 5 MG per TAB